Nuevas terapias inmunomoduladoras para la hepatitis C crónica
Salud(i)ciencia (Impresa); 15 (3), 2007
Recent clinical trials have shown that combination therapy with pegylated interferon and ribavirin can achieve a sustained virological response in the majority of patients with chronic hepatitis C who qualify for treatment. However, because many patients are unable to be treated (or choose not to due to ...